Technology
Health
Biotechnology

Alector

$14.85
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.01 (-0.07%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Alector and other stocks, options, ETFs, and crypto commission-free!

About ALEC

Alector, Inc. operates as a clinical-stage biopharmaceutical company. It develops therapeutics for the treatment of neurodegenerative diseases including frontotemporal dementia (FTD), Alzheimer's disease, and Parkinson's disease. Read More The company was founded by Asa Abeliovich, Errik B. Anderson, Tillman U. Gerngross, and Arnon Rosenthal in May 2013 and is headquartered in South San Francisco, CA.

Employees
Headquarters
South San Francisco, California
Founded
2013
Market Cap
1.02B
Price-Earnings Ratio
Dividend Yield
Average Volume
364.55K
High Today
$14.92
Low Today
$14.01
Open Price
$14.66
Volume
311.82K
52 Week High
$27.00
52 Week Low
$13.64

Collections

Technology
Health
Biotechnology
Medical
Biopharmaceutical
Therapy
Pharmaceutical
2019 IPO

ALEC Earnings

-$1.48
-$1.11
-$0.73
-$0.36
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
-$0.36 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.